Xing Zhao

Xing Zhao, M.D. Ph.D. is the Founder, Chairman & Global CEO of ReLive Biotechnologies Limited. Previously, Zhao was the Managing Director at CO.DON GmbH, and Member of the Board of Directors at Mellitus, LLC where they were involved in developing an in vitro diagnostic test for diabetes detection. They also co-founded SQZ Biotechnologies and Orient Landscape, and served as a Chair of Research Steering Committee at Vericel Corporation. With a background in orthopaedic surgery, plastic surgery, and regenerative medicine, Zhao has made significant contributions to the field of healthcare, life sciences, and biotechnology.